Dec 22, 2017   SOURCE: PR NewsWire

United States Mechanical Heart Valves Markets 2017-2018

DUBLIN, Dec. 22, 2017 /PRNewswire/ --

The "US Market Report for Mechanical Heart Valves 2018 - MedCore" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The first generation of device designs for mechanical heart valves included a caged-ball construct. These devices functioned similar in fashion to a ballpoint pen, serving as a one-way flow point for blood between the chambers of the heart. However, this design was not ideal in that the heart had to work harder to maintain flow through the valve. Subsequent generations of device design focused on an open-and-close valve, which allowed for central blood flow. Mechanical heart valves may be combined with a conduit for use in cases requiring the reconstruction of both the aortic heart valve and the aorta.

Mechanical heart valves are prosthetic devices designed to replicate the function of the natural valves of the human heart. Mechanical valves are designed to outlast the patient and some have been stress-tested to last several hundred years. Although mechanical valves are long-lasting and generally only require one surgery for installation, they contribute to an increased risk of blood clot formation. As a result, mechanical valve recipients often take anti-coagulant (blood thinning) drugs such as warfarin for the rest of their lives, which makes the patient more prone to bleeding.

Given their durability, mechanical valves are primarily indicated for younger patients and for mitral valve replacement due to its high-pressure gradient. The primary advantage of mechanical over tissue valves is that once a mechanical valve is implanted, they never wear down and rarely need to be replaced. Mechanical valves are made from either pyrolytic carbon or titanium that has been coated with pyrolytic carbon. Pyrolytic carbon is similar to graphite and is used for many biomedical applications. They also can have parts made from Teflon, polyester or polyethylene terephthalate.

Key Topics Covered:

Executive Summary
U.S. Cardiac Surgery And Heart Valve Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Coronary Artery Disease
2.1.2 Myocardial Infarction
2.1.3 Angina Pectoris
2.1.4 Heart Valve Disease
2.1.5 Congestive Heart Failure

3. Product Portfolio
3.1.1 Tissue Heart Valves
3.1.2 Mechanical Tissue Heart Valves
3.1.3 Annuloplasty Repair Devices
3.1.4 Transcatheter Aortic Valve Replacement Devices
3.1.5 Transcatheter Mitral Valve Repair Devices
3.1.6 On-Pump Coronary Artery Bypass Devices
3.1.7 Off-Pump Coronary Artery Bypass Devices
3.1.8 Endoscopic Vessel Harvesting Devices
3.1.9 Anastomosis Assist Devices
3.1.10 Transmyocardial Revascularization Devices
3.1.11 Ventricular Assist Devices
3.1.12 Intra-Aortic Balloon Pump Device
3.1.13 Temporary Artificial Heart Replacement Device
3.1.14 Remote Hemodynamic Monitoring System Devices
3.1.15 Patent Foramen Ovale Devices
3.1.16 Atrial & Ventricular Septal Defect Device
3.1.17 Left Atrial Appendage Closure Device
3.1.18 Extracorporeal Membrane Oxygenation Machine
3.2 Fda Recalls
3.2.1 Maquet
3.2.2 Medtronic
3.2.3 Heartware Inc
3.3 Clinical Trials
3.3.1 Medtronic
3.3.2 St. Jude Medical
3.3.3 Abiomed
3.3.4 Heartware Inc

4. Mechanical Heart Valve Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Mechanical Heart Valve Market
4.3.2 Mechanical Heart Valve Without Conduit Market
4.3.3 Mechanical Heart Valve With Conduit Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

Abbreviations
Appendix: Company Press Releases

Chart 1 1: Cardiac Surgery And Heart Valve Devices Market By Segment, U.S., 2014 - 2024
Chart 1 2: Cardiac Surgery And Heart Valve Devices Market Overview, U.S., 2017 & 2024
Chart 4 1: Mechanical Heart Valve Market By Segment, U.S., 2014 - 2024
Chart 4 2: Mechanical Heart Valve Market Breakdown By Segment, U.S., 2017
Chart 4 3: Mechanical Heart Valve Market Breakdown By Segment, U.S., 2024
Chart 4 4: Total Mechanical Heart Valve Market, U.S., 2014 - 2024
Chart 4 5: Mechanical Heart Valve Without Conduit Market, U.S., 2014 - 2024
Chart 4 6: Mechanical Heart Valve With Conduit Market, U.S., 2014 - 2024
Chart 4 7: Leading Competitors, Mechanical Heart Valve Market, U.S., 2017

Figure 1 1: Cardiac Surgery And Heart Valve Devices Market Share Ranking By Segment, U.S., 2017 (1 of 4)
Figure 1 2: Cardiac Surgery And Heart Valve Devices Market Share Ranking By Segment, U.S., 2017 (2 of 4)
Figure 1 3: Cardiac Surgery And Heart Valve Devices Market Share Ranking By Segment, U.S., 2017 (3 of 4)
Figure 1 4: Cardiac Surgery And Heart Valve Devices Market Share Ranking By Segment, U.S., 2017 (4 of 4)
Figure 1 5: Companies Researched in this Report, U.S., 2017
Figure 1 6: Factors Impacting the Cardiac Surgery And Heart Valve Devices Market By Segment, U.S. (1 of 4)
Figure 1 7: Factors Impacting the Cardiac Surgery And Heart Valve Devices Market By Segment, U.S. (2 of 4)
Figure 1 8: Factors Impacting the Cardiac Surgery And Heart Valve Devices Market By Segment, U.S. (3 of 4)
Figure 1 9: Factors Impacting the Cardiac Surgery And Heart Valve Devices Market By Segment, U.S. (4 of 4)
Figure 1 10: Recent Events in the Cardiac Surgery And Heart Valve Devices Market, U.S., 2015 - 2017
Figure 1 11: Cardiac Surgery And Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4)
Figure 1 12: Cardiac Surgery And Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4)
Figure 1 13: Cardiac Surgery And Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4)
Figure 1 14: Cardiac Surgery And Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4)
Figure 1 15: Procedure Codes Investigated, U.S., 2017
Figure 1 16: Cardiac Surgery And Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2)
Figure 1 17: Cardiac Surgery And Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2)
Figure 1 18: Key Report Updates (1 of 2)
Figure 1 19: Key Report Updates (2 of 2)
Figure 1 20: Version History
Figure 3 1: Tissue Heart Valves By Company
Figure 3 2: Mechanical Tissue Heart Valves By Company
Figure 3 3: Annuloplasty Repair Devices By Company
Figure 3 4: Transcatheter Heart Valve Replacement Devices By Company
Figure 3 5: Transcatheter Mitral Valve Repair Devices By Company
Figure 3 6: On-Pump Coronary Artery Bypass Devices By Company
Figure 3 7: Off-Pump Coronary Artery Bypass Devices By Company
Figure 3 8: Endoscopic Vessel Harvesting Devices By Company
Figure 3 9: Anastomosis Assist Devices By Company
Figure 3 10: Transmyocardial Revascularization Devices By Company
Figure 3 11: Ventricular Assist Devices By Company
Figure 3 12: Intra-Aortic Balloon Devices By Company
Figure 3 13: Temporary Artificial Heart Replacement Devices By Company
Figure 3 14: Remote Hemodynamic Monitoring System Devices By Company
Figure 3 15: Patent Foramen Ovale Devices By Company
Figure 3 16: Atrial & Ventricular Septal Defect Devices By Company
Figure 3 17: Left Atrial Appendage Closure Devices By Company
Figure 3 18: Extracorporeal Membrane Oxygenation Machine By Company
Figure 3 19: Class 2 Device Recall Maquet
Figure 3 20: Class 2 Device Recall Maquet
Figure 3 21: Class 2 Device Recall Maquet
Figure 3 22: Class 1 Device Recall Medtronic
Figure 3 23: Class 1 Device Recall Heartware Inc
Figure 3 24: the Medtronic Harmony Transcatheter Pulmonary Valve Clinical Study
Figure 3 25: Medtronic Transcatheter Aortic Valve Implant System (Corevalve System Family) Post Marketing Surveillance
Figure 3 26: Medtronic Corevalve Evolut R U.S. Clinical Study
Figure 3 27: Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients
Figure 3 28: Amplatzer Post-Infarct Muscular Vsd Occluder Humanitarian Device Exemption
Figure 3 29: Amplatzer Duct Occluder Ii Additional Sizes (Ado Ii As)
Figure 3 30: Heartmate 3 Ce Mark Study Long Term Follow-Up (Hm3 Ce Ltfu)
Figure 3 31: Trifecta Gt Post Market Clinical Follow-Up
Figure 3 32: Amplatzer Laa Occluder Post Approval Study (Pas)
Figure 3 33: Amplatzer Cardiac Plug Observational Post-Approval Study (Acp Pas China)
Figure 3 34: Momentum 3 Continued Access Protocol (Momentum 3 Cap)
Figure 3 35: Amplatzer Amulet Laa Occluder Trial (Amulet Ide)
Figure 3 36: Prevention of Non-Surgical Bleeding By Management of Heartmate Ii
Figure 3 37: Door to Unloading With Impella Cp System in Acute Myocardial Infarction (Dtu)
Figure 3 38: Protected Pci Study
Figure 3 39: Assessment of the Watchman Device
Figure 3 40: Watchman Flx Left Atrial Appendage Closure Device Post Approval Study
Figure 3 41: Investigational Device Evaluation of the Watchman Flx Laa Closure Technology
Figure 4 1: Mechanical Heart Valve Market By Segment, U.S., 2014 - 2024 (Us$M)
Figure 4 2: Total Mechanical Heart Valve Market, U.S., 2014 - 2024
Figure 4 3: Mechanical Heart Valve Without Conduit Market, U.S., 2014 - 2024
Figure 4 4: Mechanical Heart Valve With Conduit Market, U.S., 2014 - 2024
Figure 4 5: Drivers And Limiters, Mechanical Heart Valve Market, U.S., 2017
Figure 4 6: Leading Competitors, Mechanical Heart Valve Market, U.S., 2017
Figure 6 1: Press Release Summary

Companies Mentioned 

    --  Edwards Lifesciences
    --  St. Jude Medical
    --  Medtronic
    --  Maquet
    --  Abiomed
    --  HeartWare Inc.
    --  Sorin Group
    --  Terumo
    --  Abbott Laboratories
    --  Teleflex Medical
    --  Cardiac Assist
    --  AtriCure
    --  W.L. Gore
    --  SynCardia
    --  Boston Scientific
    --  Cryolife
    --  Berlin Heart
    --  Cardica
    --  Chase Medical
    --  Genesee Biomedical
    --  Karl Storz
    --  LifeNet Health
    --  Microline Surgical
    --  Novadaq
    --  On-X
    --  Saphena Medical
    --  SentreHeart
    --  Vitalitec



For more information about this report visit https://www.researchandmarkets.com/research/d53v6h/united_states?w=5

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-mechanical-heart-valves-markets-2017-2018-300574920.html

SOURCE Research and Markets